Inventor · disambiguated record
Matthew K. Robinson
Also filed as: ROBINSON MATTHEW · ROBINSON MATTHEW K
4 granted patents·11 pending applications·1 citations·filing 2011–2024
57Inventor score
Files withIMMUNOME INC7MEDIMMUNE LTD2ADAMS GREGORY P1DUNBRACK ROLAND1INST CANCER RES D B A THE RES INST OF FOX CHASE CANCER CT1
Top patents by PatentIndex Score
15 records- 0169US2025084174A1Therapeutic binding moleculesMEDIMMUNE LTD·Filed 2024·Application pending·0 cites
- 0265US12049506B2Therapeutic binding moleculesMEDIMMUNE LTD·Filed 2022·Granted Jul 30, 2024·0 cites·13 claims
- 0363US9611321B2Rationally-designed anti-mullerian inhibiting substance type II receptor antibodiesADAMS GREGORY P·Filed 2012·Granted Apr 4, 2017·1 cites·14 claims
- 0463US2024067704A1Antibody cocktail against sars-cov-2 spike proteinIMMUNOME INC·Filed 2023·Application pending·0 cites
- 0556US11834493B2Antibody cocktail against SARS-CoV-2 spike proteinIMMUNOME INC·Filed 2022·Granted Dec 5, 2023·0 cites·35 claims
- 0650US2024174741A1Il-38-specific antibodiesIMMUNOME INC·Filed 2022·Application pending·0 cites
- 0742US2021221914A1Ch3 domain epitope tagsIMMUNOME INC·Filed 2019·Application pending·0 cites
- 0841US2022002435A1Antibodies targeting epn1IMMUNOME INC·Filed 2019·Application pending·0 cites
- 0940US2021347895A1Exosome-targeting bispecific antibodiesIMMUNOME INC·Filed 2019·Application pending·0 cites
- 1039US11261225B2Chimera of bone morphogenic protein 2 and the Müllerian-inhibiting substance type II receptor binding region of Müllerian-inhibiting substanceTHE RES INSTITUTE OF FOX CHASE CANCER CENTER·Filed 2018·Granted Mar 1, 2022·0 cites·24 claims
- 1139US2022275077A1Il-38-specific antibodiesIMMUNOME INC·Filed 2020·Application pending·0 cites
- 1239US2013108547A1Recombinantly Produced Antibodies Targeting ErbB Signaling Molecules and Methods of Use Thereof for the Diagnosis and Treatment of DiseaseDUNBRACK ROLAND·Filed 2011·Application pending·0 cites
- 1338US2014186365A1Antibodies that specifically bind to serum albumin without interfering with albumin's capability to interact with the fcrnINST OF FOX CHASE CANCER CT INST FOR CANCER RES D B A THE RES·Filed 2013·Application pending·0 cites
- 1437US2017267727A1Conjugates of pH Low Insertion Peptide and Monomethyl Auristatins in the Treatment of Solid TumorsUNIV LEHIGH·Filed 2017·Application pending·0 cites
- 1534US2014105919A1Synergistic inhibition of erbb2/erbb3 signal pathways in the treatment of cancerINST CANCER RES D B A THE RES INST OF FOX CHASE CANCER CT·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Matthew K. Robinson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →